BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#90 of 347

Geulah Livshits

Chardan Capital · Equity Research Analyst
EstablishedRating since 2021No new ratings since May 2025

Analyst rating accuracy & track record

Geulah Livshits is an equity research analyst at Chardan Capital. Bullish Whales has scored 49 of their stock calls across 14 companies. Their picks beat their sector 43% of the time over the next 12 months, and their price targets were reached 14% of the time within a year.

Win % vs sector
43%
PT Hit % (12mo)
14%
Avg sector-excess
−0.8%
Scored calls
49
Tickers
14
Tier
Established

Track record

Bullish Whales has scored 49 of Geulah Livshits's stock calls across 14 companies, dating back to 2021. Their rated stocks beat their own sector 43% of the time over the next 12 months. On a typical call, a Livshits pick returned −0.8% more than its sector over the following year.

Of the scored calls, 49 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
TSHATaysha Gene Therapies Inc
Buy$9.00May 2025+101.9%Miss
RCKTRocket Pharmaceuticals Inc
Buy$17.00May 2025−0.8%Miss
IPSCCentury Therapeutics Inc
Buy$6.00May 2025+300.9%Miss
LXEOLexeo Therapeutics, Inc. Common Stock
Buy$20.00May 2025+98.2%Miss
TNYATenaya Therapeutics Inc
Buy$9.00May 2025+135.7%Miss
IOVAIovance Biotherapeutics Inc
Buy$25.00May 2025+84.6%Miss
FDMT4D Molecular Therapeutics Inc
Buy$25.00May 2025+217.9%Miss
IMRXImmuneering Corp
Buy$13.00May 2025+362.5%Miss
SNTISenti Biosciences Inc
Buy$12.00May 2025−77.9%Miss
LXEOLexeo Therapeutics, Inc. Common Stock
Buy$22.00Apr 2025+163.1%Miss
LXEOLexeo Therapeutics, Inc. Common Stock
Buy$25.00Mar 2025+40.5%Miss
IMRXImmuneering Corp
Buy$13.00Mar 2025+208.0%Miss
IPSCCentury Therapeutics Inc
Buy$7.00Mar 2025+302.3%Miss
TNYATenaya Therapeutics Inc
Buy$9.00Mar 2025+27.0%Miss
FDMT4D Molecular Therapeutics Inc
Buy$28.00Mar 2025+107.9%Miss
PASGPassage Bio Inc
Buy$6.00Mar 2025−17.0%Miss
IOVAIovance Biotherapeutics Inc
Buy$30.00Mar 2025−12.0%Miss
TSHATaysha Gene Therapies Inc
Buy$7.00Feb 2025+178.6%Miss
FDMT4D Molecular Therapeutics Inc
Buy$30.00Feb 2025+94.3%Miss
IMRXImmuneering Corp
Buy$13.00Jan 2025+113.3%Miss
TNYATenaya Therapeutics Inc
Buy$18.00Dec 2024−67.6%Miss
SNTISenti Biosciences Inc
Buy$12.00Dec 2024−72.2%Miss
SNTISenti Biosciences Inc
Buy$10.00Dec 2024−77.6%Hit
IMRXImmuneering Corp
Buy$13.00Nov 2024+224.3%Miss
FDMT4D Molecular Therapeutics Inc
Buy$39.00Nov 2024+13.2%Miss
PASGPassage Bio Inc
Buy$7.00Nov 2024−23.7%Miss
TNYATenaya Therapeutics Inc
Buy$18.00Nov 2024−52.7%Miss
IPSCCentury Therapeutics Inc
Buy$11.00Nov 2024−61.9%Miss
EDITEditas Medicine Inc
Buy$12.00Nov 2024−15.4%Miss
EDITEditas Medicine Inc
Buy$12.00Oct 2024+12.4%Miss
IMRXImmuneering Corp
Buy$12.00Aug 2024+225.5%Miss
LXEOLexeo Therapeutics, Inc. Common Stock
Buy$23.00Jul 2024−57.4%Miss
TNYATenaya Therapeutics Inc
Buy$20.00Mar 2024−88.5%Miss
SNTISenti Biosciences Inc
Buy$6.00Aug 2023−83.4%Miss
MGTXMeiraGTx Holdings PLC
Buy$41.00Aug 2023−44.5%Miss
PASGPassage Bio Inc
Buy$9.00Aug 2023−8.5%Miss
SNTISenti Biosciences Inc
Buy$6.00May 2023−71.2%Miss
IMTXImmatics NV
Buy$25.00Mar 2023+50.9%Miss
SNTISenti Biosciences Inc
Buy$7.00Mar 2023−81.3%Miss
MGTXMeiraGTx Holdings PLC
Buy$41.00Mar 2023−0.0%Miss
SNTISenti Biosciences Inc
Buy$8.00Jan 2023−81.0%Miss
PASGPassage Bio Inc
Buy$11.00Dec 2022−38.0%Miss
SNTISenti Biosciences Inc
Buy$12.00Sep 2022−71.1%Miss
MGTXMeiraGTx Holdings PLC
Buy$47.00Aug 2022−49.3%Miss
SLDBSolid Biosciences LLC
Buy$6.00Aug 2022−72.0%Miss
IMTXImmatics NV
Buy$28.00Aug 2022+1.3%Miss
MGTXMeiraGTx Holdings PLC
Buy$46.00May 2022−31.0%Miss
SLDBSolid Biosciences LLC
Buy$7.00Apr 2022−46.1%Miss
SLDBSolid Biosciences LLC
Buy$17.00Sep 2021−75.5%Miss
Go to

Geulah Livshits: analyst track record FAQ

Is Geulah Livshits a good stock analyst?

Yes, by track record. Geulah Livshits ranks number 90 of 347 of the analysts Bullish Whales scores, with a BW Score of 47 out of 100. Past results do not guarantee future ones.

What is Geulah Livshits's win rate?

Geulah Livshits's win rate is 43%. Across 49 scored calls, their rated stocks beat their sector 43% of the time over the next 12 months. On a typical call they returned −0.8% more than the sector.

What stocks and sectors does Geulah Livshits cover?

Geulah Livshits covers 14 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Geulah Livshits's price targets accurate?

Geulah Livshits's price targets are reached within 12 months 14% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Geulah Livshits's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Geulah Livshits rank among Wall Street analysts?

Geulah Livshits ranks number 90 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30